Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity
Khaleel I. Al‐Obaidy(Indiana University School of Medicine), Liang Cheng(Brown University), David J. Grignon(Indiana University School of Medicine), Kiril Trpkov(University of Calgary), Andrés Acosta(Indiana University Health), Ahmad Alkashash(Indiana University Indianapolis), Rola Saleeb(University of Toronto), Muhammad T. Idrees(Indiana University School of Medicine), Adeboye O. Osunkoya(Emory University), Ondřej Hes(Charles University), Rodolfo Montironi(Marche Polytechnic University), Alessia Cimadamore(University of Udine), Zainab I. Alruwaii(King Fahad Specialist Hospital), John N. Eble(Indiana University – Purdue University Indianapolis), Ankur R. Sangoi(El Camino Hospital), Lee Ann Baldrige(Indiana University Indianapolis), Mehdi Nassiri(Indiana University School of Medicine), Joyashree D. Sen(Indiana University Indianapolis), Nilesh Gupta(Henry Ford Health System), Sean R. Williamson(Cleveland Clinic), Wael Sakr(Wayne State University), Oudai Hassan(Henry Ford Health System)
Cited by 39
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705